Activation of C5L2, a G-protein-coupled receptor, by acylation-stimulating protein/complement C3adesArg (ASP/C3adesArg) has been shown to stimulate triglyceride (TG) synthesis in both mature adipocytes and preadipocytes. ASP is an adipocyte-derived hormone that acts by increasing diacylglycerol acyltransferase activity and glucose transport. ASP-deficient mice (C3KO, precursor protein) are lean, display delayed postprandial TG clearance, increased food intake, and increased energy expenditure. The present study shows that C5L2KO mice on a low fat diet are hyperphagic (w60% increase in total food intake) yet maintain the same body weight and adipose tissue mass as wild-type (WT) controls. However, on a high fat diet, average adipocyte size and adipose tissue TG/DNA content were significantly reduced and postprandial TG clearance was delayed in 4G9 . 3%, P!0 . 05) were significantly increased in C5L2KO mice versus WT (100%). The study shows that in response to reduced TG storage in white adipose tissue, C5L2KO mice have developed a compensatory mechanism of increased muscle fat oxidation.
Introduction
Adipocyte triglyceride (TG) synthesis is stimulated through activation of the C5L2 receptor by its ligand acylationstimulating protein (ASP/C3adesArg). The ASP-C5L2 pathway stimulates TG synthesis (TGS) by increasing diacylglycerol acyltransferase activity, the final enzyme in the TGS cascade (Yasruel et al. 1991 , Kalant et al. 2005 . In a paracrine and/or autocrine fashion, ASP and its arginated precursor (C3a) increase TGS in both adipocytes and preadipocytes. This has been demonstrated in human-and murine-derived cell lines, and whole tissue (Walsh et al. 1989 , Cianflone et al. 1994 . ASP has also been shown to stimulate glucose transport in adipose tissue by increasing glucose transporter 4 (GLUT-4) translocation (Maslowska et al. 1997 , Tao et al. 1997 and to inhibit lipolysis, functions which are independent and additive to insulin (van Harmelen et al. 1999) . ASP accelerates dietary postprandial TG clearance, as demonstrated in both wild-type (WT) and ASP-deficient mice given a bolus ASP injection during an oral fat load (Murray et al. 1999a , Xia et al. 2004 .
C5L2 is a G-protein-coupled receptor highly expressed in fat depots, liver, and spleen (Kalant et al. 2005) . It is a serpentine receptor related to the C5aR, C3aR, and fMLP family of chemokine receptors (Ohno et al. 2000) . This family of receptors is activated during an immune attack to recruit macrophages and neutrophils to a site of infection; however, it has been shown that C5L2 is not involved in chemotaxis response (Cain & Monk 2002) . C5L2 binds other ligands such as the ASP precursor C3a as well as structurally similar ligands C5a and C4a with varying affinities and capacities for crosscompetition. C5a binding to C5L2 in a transfected cell-based assay does not stimulate TGS, and this holds true for cells endogenously expressing C5L2 (Kalant et al. 2003) .
Moreover, ASP and C5a do not compete for the same binding sites on C5L2 (Kalant et al. 2003) . A proposed alternate function of C5L2 is to act as a decoy receptor, sequestering C5a from circulation and preventing C5a interaction with C5aR (Gao et al. 2005) . Gerard et al. (2005) recently demonstrated that C5L2KO mice have active C5aR and are more sensitive to immune attack during injury; however, lipid metabolism was not examined. It should be noted that C3a manifests the same bioactivity as ASP (Kalant et al. 2005) ; however, physiological C3a is rapidly cleaved by circulating carboxypeptidases to generate ASP. To date, ASP/C3a are the only ligands shown to activate the C5L2 receptor.
To evaluate the in vitro functional role of ASP-C5L2, C5L2 was stably transfected and overexpressed in HEK293 cells competent for both TGS and glucose transport. ASP stimulated TGS and glucose transport several fold over basal (Kalant et al. 2005) . Following ASP binding, the receptor was phosphorylated and internalized via b-arrestin translocation (Kalant et al. 2005) , a cytosolic protein that targets clathrincoated vesicle formation during endocytosis for receptor desensitization (Claing et al. 2002) . By contrast, C5L2 antisense oligos significantly reduced receptor expression, with concordant loss of ASP-stimulated TGS in the murine preadipocyte 3T3-L1 cell line, demonstrating that C5L2 is necessary and sufficient for ASP action (Kalant et al. 2005) .
The aim of the present study was to extend the above in vitro findings by examining the physiological consequences of gene knockout (KO) of C5L2 and its influence on lipid storage and energy expenditure. C5L2KO mice were characterized based on lipid parameters, muscle metabolism, and adipose tissue TGS.
Materials and Methods

Mice
C5L2 (K/C) heterozygous mice were obtained from Regeneron Pharmaceutics Inc. courtesy of Dr Joseph Sorrentino (Tarrytown, NY, USA). The methodology for development of these KO transgenic mice using the technique of VelociGene has been previously described in detail (Valenzuela et al. 2003) . Heterozygous breeding in our internal colony generated C5L2KO and WT littermates and mice were selected by PCR genotyping. Briefly, mouse tail clippings were digested overnight and DNAwas extracted using DNeasy kit (Qiagen). The PCR included PCR enhancer reagents (Invitrogen) and 25 mM each primer. Using the same forward primer: 5 0 -CTTGTTGGCCCTCTTTCTCC-3 0 , the WT gene was detected with WT reverse primer: 5 0 -GATGGG-CACAGCCAGGAAG-3 0 or the KO gene was detected with KO reverse primer: 5 0 -GTCTGTCCTAGCTTCCT-CACTG-3 0 . The reaction conditions were 40 cycles at 96 8C for 30 s, 50 8C for 30 s, and 72 8C for 30 s. The products were separated by electrophoresis on a 7% polyacrylamide gel and visualized with silver staining (Bio-Rad).
All mice were housed individually in a sterile barrier facility with 12 h light:12 h darkness at the animal facility. At 9 weeks, mice were placed on low fat (LF) diet (10% kcal fat; Charles River Laboratories, Wilmington, PA, USA) or a high fat-high sucrose (HF/HS) diet (58% kcal fat; Research Diets Inc., New Brunswick, NJ, USA) and were killed at 21 weeks of age after 12 weeks on diets. All protocols were approved and were conducted in accordance with the CACC guidelines and approved by the University Animal Care Committee. (FlukaRiedel, Buchs, Switzerland) , and all other chemicals were from Sigma (Sigma-Aldrich).
Chemicals
Body weight, food intake, and body composition Body weight and food intake (15-21 weeks) were measured twice weekly. Body composition to measure total percent body fat was measured by dual-energy X-ray absorptiometry (DEXA) using the PIXIMUS mouse densitometry apparatus (Lunar Corporation, Madison, WI, USA) at 21 weeks of age. Mice were given an i.m. injection for general anesthesia before the scan. Oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), and the respiratory quotient (RQ) were measured over a 48-h period in an open circuit system with the S-3A1 oxygen analyzer (Applied Electrochemistry, Pittsburgh, PA, USA) and the CD-3A carbon dioxide analyzer (Applied Electrochemsitry). VO 2 and VCO 2 were calculated as ml/kg per h and RQ was taken as the quotient of VCO 2 /VO 2 .
Plasma assays
Fasting plasma samples were taken at the time of killing by cardiac puncture. Plasma TGs and non-esterified fatty acids (NEFA) were measured using colorimetric enzymatic kits (Roche Diagnostics and Wako Chemicals, Richmond, VA, USA respectively). Glucose was measured using the Trinder glucose kit (Sigma). Insulin, leptin, and adiponectin were measured using RIA kits (Linco, St Charles, MO, USA).
Adipose tissue histology
Gonadal tissue was preserved in 4% paraformaldehyde. Tissue sections were cut 4 mm thick and fixed onto slides using standard histological methods. Slides were stained with hematoxylin and eosin (H&E) dye. Adipocyte volume (50 cells/mouse) was measured using Image-Pro Plus (Media Cybernetics INC, Bethesda, MD, USA) under 20! magnification (Olympus, Center Valley, PA, USA).
Adipose tissue TG mass TG was extracted from gonadal adipose tissue overnight in 500 ml heptane-isopropanol (3:2) at 4 8C. TG content was measured using a colorimetric kit as described above. Tissue samples were homogenized with a polytron homogenizer for 20 s in tissue lysis buffer (50 mM NaH 2 PO 4 , 2 M NaCl, 2 M EDTA, pH 7 . 6). Total DNA was measured by a DNA quantification kit (Sigma) and results are presented as moles TG/mg DNA.
Lipogenesis and lipolysis assay
Mouse gonadal adipose tissue was collected after killing and placing in room temperature PBS, cut into very small pieces (10-20 mg) and placed into a 48-well plate. Fresh tissue pieces rather than isolated adipocytes are commonly used to examine lipogenesis and lipolysis in white adipose tissue (WAT; Faraj & Cianflone 2004 , Festuccia et al. 2006 . The tissue was treated with insulin (100 nM), the non-selective b-agonist isoproterenol (10 mM), ASP (10 mM), or vehicle (PBS) in 200 ml Ca 2C -free KrebsRinger Buffer (KRB) containing 1% fatty acid-free BSA, 5 mM glucose, and D-[1-14 C]glucose (1 mCi/ml) for 3 h at 37 8C. The plate was placed on ice to stop the reaction, and the buffer was removed and stored at K20 8C for NEFA and glycerol analysis. Tissue lipids were extracted overnight in 500 ml heptane-isopropanol (3:2) at 4 8C. The following day, lipids were re-extracted from the tissue fragments and the two pools were combined and the solvent evaporated. To select for neutral lipids (TGs), alumina was added to each sample (0 . 1 g/ml) to bind phospholipids (Neri & Frings 1973) , mixed for 15 min at room temperature, centrifuged at 3000 g for 15 min at 4 8C and 500 ml supernatant was transferred to a scintillation vial and counted. TG constitutes 85-90% of the total labeled lipid product (unpublished observation). Soluble protein was extracted and measured as described above. Results are expressed as pmol/mg protein. NEFA and glycerol released by the tissue into the buffer were measured using colorimetric enzymatic commercial kits described above. Results are expressed as nmol/mg protein. Percent re-esterification was calculated as 100! ((glycerol release!3)-NEFA release)/(glycerol release!3). In a separate experiment, isolated adipocytes were prepared from fresh adipose tissue by collagenase digestion (1 mg/ml type II collagenase, 2 mM glucose, and 2% fatty acid free BSA) for 45 min at 37 8C with shaking. Isolated adipocytes were counted with a hemocytometer and 2!10 4 cells per aliquot were used for the TGS assay. Basal TGS was measured in KRB containing 1% fatty acid-free BSA, 5 mM glucose, D-[1-14 C]glucose (1 mCi/ml) and 100 mM [ 3 H]oleate (5 mCi/ml) for 4 h at 37 8C with shaking as previously described by Walsh et al. (1989) .
Fat load and glucose tolerance test (GTT)
At 15 weeks of age, following an overnight fast, 300 ml olive oil (with 100 ml air above the oil) was administered by intragastric gavage feeding tube as described previously (Murray et al. 1999a ). Blood samples were taken by saphenous vein bleeding at time 0, 2, 3, 4, and 6 h after the fat load. GTT was performed on adult mice (5-6 months of age) following an overnight fast. Blood samples were taken at 0, 15, 30, 60, and 120 min after an i.p. glucose injection (2 mg/g body weight). For both protocols, blood (40 ml) was collected in 2% EDTA, separated by centrifugation at 5000 g for 5 min and stored at K20 8C for further analysis.
Fecal analysis
Total fecal lipids were analyzed as previously described (Murray et al. 2000) to assess intestinal fat absorption. Fecal samples were collected over a 24-h period in a subset of mice on normal LF diet (10% kcal fat).
Palmitate oxidation and incorporation into TG
Skeletal muscle (quadriceps), heart, and liver tissues were collected after killing and placed in room temperature PBS. The tissue was cut into small pieces (10-20 mg) and placed into a 48-well plate. The tissue was treated with Ca 2C -free KRB (200 ml) containing 1% BSA, 5 mM glucose, and 1 mM palmitic acid [ 3 H palmitate, 5 mCi/ml] for 2 h at 37 8C. A Folch extraction was performed with the addition of 2 . 5 ml chloroform/methanol (2:1) and 1 ml KCl:HCl to separate the organic from the aqueous phase. The mixture was vortexed then centrifuged at 3000 g for 5 min and an aliquot of the aqueous phase containing the oxidative product 3 H 2 O, was taken for scintillation counting as previously described (Ibrahimi et al. 1999 , Abu-Elheiga et al. 2003 . The organic phase, containing 3 H-TG, was separated by thin layer chromatography (TLC) and processed as described elsewhere (Kalant et al. 2005) . Soluble protein was extracted overnight from the remaining tissue with 500 ml of 0 . 3 M NaOH. The samples were diluted with water to yield a final concentration of 0 . 1 M NaOH and protein levels were determined using the Bradford assay (Bio-Rad).
Western blot
Total protein was homogenized from frozen skeletal muscle (quadriceps muscle) samples with lysis buffer (1 mM EDTA, 0 . 4 mM phenylmethylsulfonyl fluoride in PBS), SDS gel sample buffer was added and protein extracts were separated on a 12% acrylamide/bis gel (10 and 7 . 5% gel for assaying GLUT-4 and acetyl CoA carboxylase (ACC) respectively) at 200 V for 45 min. The proteins were transferred to nitrocellulose via electroblotting (60 min at 100 V). Standard blocking and incubation procedures were followed. Primary antibodies used were rabbit anti-mouse cytochrome c (BD Pharmingen Tech, San Jose, CA, USA) and uncoupling protein 3 (UCP3; in-house) antibodies, which were followed by peroxide-conjugated swine antirabbit immunoglobulin secondary antibody (Dako, Glostrup, Denmark). Primary anti-murine CD36 (clone 36) antibody (Cascade Bioscience, Winchester, MA, USA) was followed by goat anti-mouse IgA HRP antibody (Southern Biotechnology Ass., Birmingham, AL, USA). After incubation, blots were rinsed in PBS, visualized with West Dura Extended Duration Substrate and exposed on CL-Xposure film (Pierce Biotechnology Inc., Rockford, IL, USA) and analyzed by computer-assisted photodocumentation system. GLUT-4 was visualized using the Odyssey (LI-COR Biotechnology, Lincoln, NE, USA) imaging system. Primary antibody GLUT-4 (in house) and secondary donkey anti-rabbit IR800 antibodies were used for detection. Phosphorylated ACC was detected using primary anti-phospho-ACC (Ser79) antibody rabbit polyclonal IgG (Upstate, Lake Placid, NY, USA) and secondary goat-anti-rabbit HRP-conjugated antibody. Phosphorylation levels were visualized with enhanced chemiluminescent (ECL) western blotting detection (GE Healthcare, Buckinghamshire, UK) using UVP (Upland, CA, USA) photodocumentation system.
AMP-activated protein kinase (AMPK) activity assay
AMPK activity was measured as previously described by Sambandam et al. (2004) . Briefly, 20 mg frozen tissue (quadriceps muscle) was homogenized in 200 ml homogenization buffer (50 mM Tris-HCl (pH 8) at 4 8C, 1 mM EDTA, 10% (wt/v) glycerol, 0 . 02% (v/v) Brij-35, 1 mM dithiothreitol) containing protease and phosphatase inhibitors. Protein homogenates were centrifuged at 10 000 g for 20 min at 4 8C and protein content was measured by the Bradford assay (Bio-Rad). AMPK activity was determined by the incorporation of [g-32 P]ATP into a synthetic peptide, AMARA (Upstate). The assay was performed in a total volume of 25 ml containing 80 mM HEPES-NaOH (pH 7 . 0), 160 mM NaCl, 1 . 6 mM EDTA, 1 mM MgCl 2 , 16% glycerol, 200 mM AMARA peptide, 2 mM [g-32 P]ATP (400-600 dpm/pmol), and 5 ml protein homogenate. The reaction was performed in both the absence and presence of AMARA at 30 8C for 15 min (AMPK-specific phosphorylation activity). The reaction was stopped with the addition of 3% H 3 PO 4 then 10 ml aliquots of reaction solution were removed and spotted on P81 phosphocellulose paper (Whatman, Florham Park, NJ, USA). The papers were washed, dried, and placed in vials containing 5 ml scintillation fluid. Radioactivity was determined using standard liquid scintillation procedures.
Statistical analyses
Results are presented as meanGS.E.M. In all cases, there was no difference between male and female mice, and results were pooled. Groups were compared by t-tests, one-or two-way ANOVA followed by Bonferroni post hoc test or Wilcoxon signed rank test as indicated. Statistical significance was set at P!0 . 05, where ns indicates not significant.
Results
C5L2KO mice on LF diet display increased food intake relative to weight gain
Male and female WT and C5L2KO mice were placed on LF or HF/HS diets for 12 weeks. Over the course of this study no body weight differences were observed between WT and C5L2KO mice on either LF or HF/HS diets (Fig. 1A) . However, relative to body weight gain, the C5L2KO-LF mice had almost a two-fold increase in cumulative food intake when compared with WT mice (WT-LF: 511 . 4G2 . 2 kJ versus C5L2KO-LF: 821G37 . 4 kJ, P!0 . 0001, nZ4 per group), resulting in a concomitant decrease in food efficiency Figure 1 Body weight and food efficiency. Mouse body weight at 21 weeks for WT (white bars) and C5L2KO (grey bars) mice on a LF and HF/HS diet (A). Food efficiency over a 6-week period (15-21 weeks) (B). Food efficiency is calculated as average weight gain (g)/food intake (kJ) for WT (white bars) and C5L2KO (grey bars), nZ4-6 mice. Values are presented as meanGS.E.M. where *P!0 . 05 denotes significant differences between WT and C5L2KO evaluated by t-test.
S PAGLIALUNGA and others . C5L2KO mice and the ASP-C5L2 pathway as shown by the ratio of weight gain/food intake (Fig. 1B) . Food intake and food efficiency results for WT-HF/HS and C5L2KO-HF/HS mice were similar to each other, but substantially different from LF diet (Fig. 1B) .
Adiposity and adipose tissue analysis C5L2KO-LF mice showed no significant difference in either total percent body fat when compared with WT-LF mice measured by DEXA (WT-LF: 21 . 6G4 . . 4G2 . 4% body fat, ns, nZ4 per group) or gonadal adipose tissue weight (WT-LF: 0 . 76G0 . 26 g and C5L2KO-LF: 0 . 80G0 . 15 g, ns, nZ4 per group). Furthermore, histological analysis revealed similar adipocyte cell size and TG content between the two groups (Fig. 2) . On the HF diet, the total percent body fat of each mouse strain almost doubled when compared with LF counterparts. Again there were no differences between WT and C5L2KO mice for percent Fig. 2A and B) . Total DNA per adipose tissue weight was increased (Fig. 2C) and adipose tissue TG content per unit DNA was also substantially reduced in C5L2KO-HF/HS when compared with WT-HF/ HS mice (Fig. 2D ).
C5L2KO mice have reduced adipose tissue TGS
Gonadal adipose tissue samples were incubated ex vivo to evaluate basal TGS. Basal TGS was markedly decreased in C5L2KO-LF mice when compared with WT-LF mice (Fig. 3A , P!0 . 001). As intact adipose tissue pieces preserve the microenvironment, local ASP production in adipose tissue from WT mice will act upon the C5L2 receptors in proximity to stimulate TGS, while the adipose tissue from C5L2KO mice will not benefit from this activity due to the absence of C5L2 receptors. Accordingly, isolated adipocytes were prepared from gonadal adipose tissue from a younger subset of mice (10 weeks) and assayed for basal TGS in the absence of ASP. Under these conditions, there was no difference in basal TGS between WT and C5L2KO mice (15 . 5G6 . 8 pmol/2!10 4 cells, nZ15 samples versus 12 . 8G 2 . 5 pmol/2!10 4 cells, nZ12 samples respectively, ns). Meanwhile, paired tissue pieces prepared and assayed simultaneously maintained the differences noted between WT and C5L2KO mice (12 . 7G4 . 0 pmol/mg, nZ15 and 6 . 3G1 . 6 pmol/mg, nZ12 respectively, PZ0 . 0584). Table 1 outlines the effect of direct stimulation by insulin or ASP on TGS. Insulin-stimulated TGS up to 251G16% in WT mice on LF diet, whereas ASP stimulation increased TGS by 145G17% (both P!0 . 05 when compared with no stimulation). By contrast, there was no stimulatory effect by ASP on C5L2KO adipose tissue, providing further evidence that C5L2 is the ASP receptor for TGS. Interestingly, the response to insulin was also reduced in C5L2KO mice when compared with WT mice, suggesting an altered insulin response in adipose tissue. In the present study, after chronic HF feeding (12 weeks), obese WT-HF/ HS mice demonstrated a decreased basal TGS when compared with WT-LF mice (Fig. 3A) . A similar reduction in basal TGS was seen in the C5L2KO-HF/HS diet mice. Nonetheless, in spite of the HF/HS diet, both insulin-and ASP-stimulated TGS in WT adipose tissue, with no stimulation in C5L2KO tissue (Table 1) .
Lipolysis, measured as basal glycerol release, is shown in Fig. 3B . Overall, adipose tissue from C5L2KO-LF mice had an w80% reduction in glycerol release when compared with WT-LF. Basal lipolysis in WT-HF/HS mice and in C5L2KO-HF/HS mice was not significantly different from WT-LF mice. b-Agonist isoproterenol significantly stimulated glycerol release in all groups (Table 2) to the same extent as assessed by one-way ANOVA (ns, Table 2 ).
Fatty acids released by adipose tissue into the media can be taken back up by the adipocytes and re-esterified to generate TG. A 100% re-esterification indicates that all of the released fatty acids are taken back up by adipose tissue to form TG. A decrease in re-esterification implies a lower capacity of fatty acid re-uptake and storage. As with TGS and lipolysis, C5L2KO-LF adipose tissue displayed reduced basal re-esterification relative to WT-LF (P!0 . 001, Fig. 3C ). While the HF/HS diet also reduced re-esterification in WT-HF/HS 14 C]glucose incorporation into TG expressed as pmol/mg protein (A). Basal TG lipolysis was measured as glycerol release into media expressed as nmol/mg protein (B). Basal % fatty acid re-esterification calculated as described in Methods (C). Results are presented as meanGS.E.M. for WT LF nZ6 (white bars), C5L2KO LF nZ9 (grey bars), WT HF/HS nZ6 (white hatched bars), and C5L2KO nZ9 (grey hatched bars) samples, where **P!0 . 001 indicates significant differences from WT LF as determined by one-way ANOVA. S PAGLIALUNGA and others . C5L2KO mice and the ASP-C5L2 pathway mice, C5L2KO-HF/HS mice had an even greater reduction when compared with WT cohorts (P!0 . 001).
C5L2KO mice have delayed postprandial dietary TG clearance
Fasting lipid and hormone values are presented in Table 3 . While there were no significant differences among the LF mice, fasting TG, leptin, and insulin were increased in C5L2KO-HF/HS when compared with WT-HF/HS. Based on the function of the ASP-C5L2 pathway, postprandial fat clearance was evaluated (Fig. 4) . C5L2KO-LF diet mice tended to have delayed TG clearance when compared with WT-LF diet mice (PZ0 . 08, Fig. 4A and C) . HF/HS diet resulted in increased postprandial lipemia in both WT and C5L2KO mice (diet effect P!0 . 0001 by two-way RM ANOVA). The delay in TG clearance observed in C5L2KO-LF mice was significantly amplified by the HF/HS diet (P!0 . 05, Fig. 4B and C) . Nonetheless, the circulating TG levels still returned to fasting values by the 4-h time point. No significant genotype-related differences were observed during the postprandial increase in NEFA levels for LF mice (area under the curve (AUC) WT-LF: 3 . 85G0 . 34 mmol/l*h and AUC C5L2KO-LF: 3 . 67G0 . 34 mmol/l*h, ns, nZ4 per group) and HF/HS diet mice (AUC WT-HF/HS: 8 . 22G0 . 54 mmol/l*h and AUC C5L2KO-HF/HS: 8 . 67G 1 . 00 mmol/l*h, ns, nZ6 per group). Intestinal lipid absorption was analyzed by measuring percent total fecal lipids/stool weight; no differences were observed between WT (1 . 67G0 . 38%, nZ3) and C5L2KO mice (0 . 98G0 . 08%, nZ5, ns), indicating that differences in TG clearance rates are not due to intestinal lipid malabsorption.
C5L2KO mice have altered glucose metabolism
The GTT revealed that C5L2KO mice had delayed glucose clearance (Fig. 5) . Although insulin levels during the GTT were not different among the LF mice, on the HF/HS diet insulin AUC was twofold greater in C5L2KO-HF/HS mice. Despite this significant delay in glucose clearance, fasting glucose levels were similar between WT and C5L2KO mice (Table 3 ) with no change in skeletal muscle GLUT-4 protein levels as assessed by western analysis (data not shown).
Evaluation of fatty acid oxidation
The increased food intake despite similar weight gain in C5L2KO-LF mice suggests increased energy expenditure. This possibility was tested by whole body indirect calorimetry. VO 2 was not significantly different between WTand C5L2KO mice (Fig. 6A) . Figure 6B and C indicates that C5L2KO-LF mice had a significantly lower RQ value when compared with WT-LF mice throughout the day, suggesting preferential oxidation of fatty acids over carbohydrates. As muscle is a major contributor to whole body substrate metabolism, we examined if C5L2KO-LF mice had increased muscle fatty acid oxidative capacity (Fig. 7A) . Indeed, ex vivo tissue palmitate oxidation was significantly increased in cardiac muscle (P!0 . 05) with a smaller increase in skeletal muscle (PZ0 . 056), while palmitate oxidation in the liver was reduced (P!0 . 05). At the same time, palmitate incorporation into TG in both heart and liver were significantly elevated in C5L2KO mice, with no change in skeletal muscle TGS (Fig. 7B) . Alterations in skeletal muscle energy metabolism markers
Skeletal muscle western blot analysis showed a significant increase in cytochrome c, CD36, and UCP3 levels in C5L2KO-LF mice versus WT-LF mice ( Fig. 7C and D) . Increased content of these proteins is consistent with the observed increased capacity for energy formation and fat utilization within muscle. Furthermore, ACC phosphorylation was elevated in C5L2KO-LF mice ( Fig. 7E and D) , although it was not associated with augmented AMPK activity (Fig. 7F) . However, there was a striking twofold increase in AMPK activity in C5L2KO-HF/HS skeletal muscle when compared with WT-HF/HS (P!0 . 0001).
Discussion
On a LF diet, the prominent features of the C5L2KO mice include i) increased food intake and reduced food efficiency; ii) a small delay in postprandial TG clearance with markedly decreased capacity for adipose tissue TG storage and re-esterification; and iii) preferential fatty acid oxidation as indicated by reduced RQ value, increased ex vivo muscle fatty acid oxidation, and increased expression of proteins involved in skeletal muscle energy metabolism. Of note, the alterations in food intake and fatty acid oxidation occurred without a detectable increase in VO 2 ; other indicators of energy expenditure such as physical activity and heat production, as previously demonstrated in ASP-deficient C3KO mice (Xia et al. 2002 (Xia et al. , 2004 , were not determined. Nonetheless, the compensatory increase in fatty acid oxidation is likely consequent to a decreased capacity for TGS and fatty acid re-esterification. A normal chow mouse diet contains relatively little dietary fat; therefore, a large majority of adipose tissue fat is derived from de novo synthesis. On a HF/HS diet, with increased fat available from the diet, the de novo fatty acid synthesis pathway is downregulated. Challenging mice with a HF/HS diet masked some differences in C5L2KO mice otherwise observed with LF diet and emphasized other differences. For example, the HF/HS diet increased food efficiency in both the WT and C5L2KO mice relative to LF, masking a strong genotype difference seen with the latter. Furthermore, the differences between C5L2KO and WT in skeletal muscle protein content (cytochrome c, CD36, UCP3) were less marked on HF/HS, but there was a marked increase in AMPK activity in C5L2KO relative to WT. Similarly, HF/HS downregulated adipose tissue basal TGS which masked the decrease in C5L2KO mice, while in contrast, adipocyte size, adipose tissue TG/DNA, and delayed postprandial plasma TG clearance in C5L2KO mice were strikingly exaggerated, and fatty acid re-esterification was further suppressed.
We have previously investigated the role of the ASP-C5L2 pathway using ASP-deficient C3KO mice (Murray et al. 1999a ,b, 2000 , Xia et al. 2004 . While not all studies agree with our results (Wetsel et al. 1999) , Pekna et al. (1998) independently derived a C3KO mouse colony, demonstrating that C3KO mice on an atherogenic background (ApoE and low density lipoprotein (LDL) receptor KO mice) were characterized by substantially decreased adipose tissue and altered plasma lipoprotein profile (Persson et al. 2004) . In agreement, we have previously shown C3KO mice are lean, and as a consequence are resistant to obesity even on a HF diet Figure 4 Postprandial dietary fat load clearance. Plasma triglyceride (mmol/l) in WT mice (squares) and C5L2KO mice (circles) on low fat (LF) diet (A) and high fat/high sucrose (HF/HS) diet (B), over 6 h after fatload. Statistical differences were determined by two-way RM-ANOVA with Bonferroni post hoc test. Incremental area-undercurve (mmol/l!h) of TG clearance curves from WT (white bars) and C5L2KO (grey bars) for nZ4-6 mice are shown in (C). Statistical differences determined by t-test. Values are presented as meanG S.E.M., where *P!0 . 05, **P!0 . 01, ***P!0 . 0001. S PAGLIALUNGA and others . C5L2KO mice and the ASP-C5L2 pathway Figure 5 Glucose tolerance test. Plasma glucose (mmol/l) levels over 120 min after i.p. glucose injection in WT mice (squares) and C5L2KO mice (circles) on low fat (LF) diet (A) and high fat/high sucrose (HF/HS) diet (B). Insert: insulin incremental area-under-curve (ng/l!min) during glucose tolerance test for WT (white bars) and C5L2KO (grey bars) for nZ6-7 mice. Statistical differences were determined by RM-ANOVA (glucose) followed by Bonferroni post hoc test and t-test (insulin). Values are presented as meanGS.E.M., where *P!0 . 05, **P!0 . 01, ***P!0 . 0001. (Murray et al. 2000) . Whereas in the present study there were no differences between C5L2KO and WT mouse body weight or adiposity, there was a striking increase in food intake, likely providing a compensatory mechanism to maintain a normal body weight and adiposity in the C5L2KO mice. Nonetheless, there were still alterations in adipose tissue metabolism. Background strain may also contribute to the small differences observed between C3KO and C5L2KO mice. In the present study, the C5L2KO mice were on an obesity-prone C57Bl/6 background, while the majority of our C3KO mice studies were on a 129Sv background (Murray et al. 1999a ,b, 2000 , Xia et al. 2004 . Figure 7 Fatty acid oxidation and skeletal muscle analysis. Tissue palmitate oxidation (nmol/mg protein) (A) and palmitate incorporation into TG (pmol/mg protein) (B) in WT LF nZ9 (white bars) and C5L2KO LF nZ15 (grey bars) samples. Skeletal muscle western blot analysis of cytochrome c (Cyto c), CD36, and uncoupling protein 3 (UCP3) (C). Values are expressed as % control where WT LF was set as 100%; WT LF nZ4 (white bars), C5L2KO LF nZ4 (grey bars), WT HF/HS nZ6 (white hatched bars), and C5L2KO HF/HS nZ6 (grey hatched bars). Representative western blots for wild-type (W) and knockout (K) mice (D). Skeletal muscle phospho-ACC levels determined by western blot analysis for WT (white bars) and C5L2KO (grey bars) (E 
